Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Mesoblast Ltd ADR (NQ: MESO ) 6.660 +0.260 (+4.06%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 16, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Mesoblast Ltd ADR < Previous 1 2 3 4 5 6 Next > BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities July 06, 2023 BioRestorative Therapies Inc. (NASDAQ: BRTX) has received a unanimous recommendation to proceed in its Phase 2 clinical trial for chronic lumb Via Benzinga William Blair Initiates Mesoblast Soon After Its Lead Product Goes Under FDA Review In Pediatric Indication March 09, 2023 Via Benzinga Why Miromatrix Medical Shares Are Trading Lower By 40%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session March 08, 2023 Gainers Kimball International, Inc. (NASDAQ: KBAL) shares jumped 84.9% to $12.40 after HNI Corporation announced it will acquire the company for $485 million. Via Benzinga Short Volatility Alert: Mesoblast Limited July 21, 2022 On Wednesday, shares of Mesoblast Limited (NASDAQ: MESO) experienced volatile short activity. After the activity, the stock price went up +2.77% to $3.34. The overall sentiment for MESO has been... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session March 08, 2023 Via Benzinga Mesoblast, Arlo Technologies, CPI Card Group And Other Big Stocks Moving Higher On Wednesday March 08, 2023 U.S. stocks traded mixed, with the Nasdaq Composite gaining around 30 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga Mesoblast's Lead Drug Candidate Goes Under FDA Priority Review For Bone Marrow Transplant Complications In Kids March 08, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 08, 2023 Via Benzinga Why Rigel Pharmaceuticals Shares Are Trading Higher By Over 30%; Here Are 20 Stocks Moving Premarket March 08, 2023 Gainers Fresh Tracks Therapeutics, Inc. (NASDAQ: FRTX) rose 51.1% to $2.66 in pre-market trading after the company disclosed topline results from single and multiple ascending dose parts of Phase 1... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday March 08, 2023 We're getting into the biggest pre-market stock movers traders will want to keep an eye on Wednesday with the latest news! Via InvestorPlace Dow Dips 300 Points; Snap Shares Plunge February 01, 2023 U.S. stocks traded lower midway through trading, with the Dow Jones dropping over 300 points on Wednesday. The Dow traded down 0.91% to 33,774.70 while the NASDAQ fell 0.33% to 11,546.13. The S&P 500... Via Benzinga Silicon Laboratories, Credit Acceptance, Stryker And Other Big Stocks Moving Higher On Wednesday February 01, 2023 U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga US Stocks Open Lower; Dow Drops 125 Points February 01, 2023 U.S. stocks traded lower this morning, with the Dow Jones dropping around 125 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.37% to 33,960.34 while the NASDAQ fell... Via Benzinga Why Leslie's Shares Are Trading Lower By Over 9%? Here Are 60 Stocks Moving In Wednesday's Mid-Day Session November 30, 2022 Gainers Biophytis S.A. (NASDAQ: BPTS) shares jumped 114% to $0.7496. Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) rose 74.1% to $0.2115. Via Benzinga Workday, XPeng, Titan Machinery And Some Other Big Stocks Moving Higher On Wednesday November 30, 2022 U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session. Via Benzinga Mesoblast Lead Product Shows Durable Long-Term Survival At Four Years In Kids With Graft Versus Host Disease November 23, 2022 Via Benzinga A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field October 14, 2022 Biotechnology companies have broken many medical barriers in the past 40 years, harnessing the technological revolution to bring innovative solutions to medical problems. Via TheNewswire.com A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field October 14, 2022 By David Willey, Benzinga Via News Direct A Look At Some Of The Companies Innovating In the Cutting-Edge Regenerative Medicine Field October 13, 2022 Biotechnology companies have broken many medical barriers in the past 40 years, harnessing the technological revolution to bring innovative solutions to medical problems. Via Benzinga Why Oil-Related Stocks Traded Higher; Here Are 74 Biggest Movers From Yesterday October 04, 2022 Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) shares surged 637.6% to close at $2.01 on Monday after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per... Via Benzinga Why Tesla Shares Are Trading Lower By Over 7%, Here Are 52 Stocks Moving In Monday's Mid-Day Session October 03, 2022 Gainers LogicBio Therapeutics, Inc. (NASDAQ: LOGC) gained 641% to $2.0207 after the company announced it will be acquired by AstraZeneca's subsidiary, Alexion, for $2.07 per share. Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday July 19, 2022 We're starting off the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday! Via InvestorPlace Benzinga's Top Ratings Upgrades, Downgrades For September 6, 2022 September 06, 2022 Upgrades Via Benzinga R&D Efforts for Alzheimer’s Therapies on the Rise with over 120 Drugs in Development March 31, 2022 Palm Beach, FL – March 31, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is an irreversible, progressive neurodegenerative disease. It is the most common cause of dementia... Via FinancialNewsMedia 87 Biggest Movers From Yesterday March 10, 2022 Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) shares jumped 150% to close at $3.80 on Wednesday. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to... Via Benzinga 50 Stocks Moving In Wednesday's Mid-Day Session March 09, 2022 Gainers Sunshine Biopharma, Inc. (NASDAQ: SBFM) rose 148% to $3.78. Sunshine Biopharma, last month, priced its 1.88 million unit uplisting to Nasdaq at $4.25 per unit. Direct... Via Benzinga 12 Health Care Stocks Moving In Wednesday's Pre-Market Session March 09, 2022 Gainers Sunshine Biopharma (NASDAQ:SBFM) stock rose 222.4% to $4.9 during Wednesday's pre-market session. The company's market cap stands at $21.9 million. TC... Via Benzinga Single Dose Of Mesoblast's Cell Therapy Shows Durable Reduction In Back Pain January 12, 2022 Mesoblast Limited (NASDAQ: MESO) announced 36-month follow-up results from the 400-subject Phase 3 trial of its allogeneic cell therapy rexlemestrocel-L in patients... Via Benzinga Alzheimer’s Disease Expected to Triple by 2050 While the Development Process for Potential Drug Candidates Increases January 05, 2022 Palm Beach, FL – January 5, 2022 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is the most common reason of progressive dementia in the elderly population. There has been an... Via FinancialNewsMedia Topics Death Exposures Death 12 Health Care Stocks Moving In Thursday's Pre-Market Session December 16, 2021 Gainers Calliditas Therapeutics (NASDAQ:CALT) stock rose 41.09% to $26.3 during Thursday's pre-market session. The market value of their outstanding shares is at $688.... Via Benzinga < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.